Shih-ping Hsu
Taoyuan City, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Non-Classical Monocyte Expansion Is Independently Associated with Anemia Severity in Patients with ESKD: The Immunity in End-Stage Renal Disease Cohort-Study.
Journal: Kidney360
Published: March 09, 2026
Short-term effects of therapeutic diet on bone turnover markers in hemodialysis patients: an exploratory analysis of a randomized crossover trial.
Journal: Scientific reports
Published: November 05, 2025
Aging-associated immune signature as a predictor of mortality in end-stage renal disease: results from the longitudinal iESRD study.
Journal: Immunity & ageing : I & A
Published: October 12, 2025
Longitudinal dynamics of humoral immune responses following serial COVID-19 vaccinations and breakthrough infections in dialysis patients.
Journal: Human vaccines & immunotherapeutics
Published: September 16, 2025
Reference intervals for urine creatinine-to-specific gravity ratio as an indicator of relative creatinine excretion rate: a cross-sectional study.
Journal: Annals of medicine and surgery (2012)
Published: December 20, 2024
Employing urinary biomarkers to infer the absence of acute kidney disease in outpatients with a single serum creatinine measurement.
Journal: Renal failure
Published: November 27, 2024
Gut microbial signatures associated with uremic pruritus in hemodialysis patients.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: September 13, 2024
Carvedilol through ß1-Adrenoceptor blockade ameliorates glomerulonephritis via inhibition of oxidative stress, apoptosis, autophagy, ferroptosis, endoplasmic reticulum stress and inflammation.
Journal: Biochemical pharmacology
Published: May 20, 2024
Percutaneous Coronary Intervention With a Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients Receiving Dialysis: A National Study From Taiwan.
Journal: Kidney medicine
Published: February 02, 2024
Extremely Low Dose of Erythropoiesis-Stimulating Agent May Be Associated with Increased Mortality in Hemodialysis Patients.
Journal: American journal of nephrology
Published: December 20, 2022
Last Updated: 09/26/2026